What percentage of patients who, for symptomatic reasons, have been switched from LT4 monotherapy to DTE, do you find actually improve on DTE, and what do they report?
What percentage of patients who, for symptomatic reasons, have been switched from LT4 monotherapy to DTE, do you find actually improve on DTE, and what do they report?
William G. Blackard Professor of Medicine Chair, Division of Endocrinology Diabetes and Metabolism Department of Internal Medicine Virginia Commonwealth University Director, VCU Health Diabetes Program Richmond, Virginia
